Progress in Studies on Diagnosis and Surgical Treatment of Refractory Ulcerative Colitis
10.3969/j.issn.1008.7125.2022.01.010
- Author:
Shuai XIONG
1
;
Pengning WU
1
;
Shuanglan CHEN
1
;
Yi ZHANG
2
Author Information
1. Department of Gastroenterology, Hospital of Chengdu, University of TCM
2. Clinical Medical College, Chengdu University of Traditional Chinese Medicine
- Publication Type:Journal Article
- Keywords:
Diagnosis;
Operative;
Postoperative Complications;
Refractory Ulcerative Colitis;
Surgical Procedures
- From:
Chinese Journal of Gastroenterology
2022;27(1):52-56
- CountryChina
- Language:Chinese
-
Abstract:
Ulcerative colitis (UC) is a chronic immune-mediated gastrointestinal inflammatory disease, the etiology has not been fully clarified. As a developing and emerging industrialized country, China is about to enter or has entered the stage of ' accelerated incidence rate and compound epidemic' of UC. Evaluate the clinical condition of refractory ulcerative colitis (RUC) at its early stage and select appropriate treatment is important. Although the kinds of drug become more and more, the rate of colon resection remains unchanged. When drug therapy cannot improve the symptoms of patient, surgical treatment should be considered. This article reviewed the progress in studies on diagnosis and surgical treatment of RUC.
